In April 2019 the data unit provided analysis for a report on the decision to make Pregabalin and Gabapentin Class C substances. The decision came into effect on 1 April 2019.
We analysed the prescriptions data at OpenPrescribing.Net to find out how much the use of these drugs has increased and the areas it’s increased the most.
- Chris and Viv Jolly, whose daughter, Sarah, died after taking the drug, which was prescribed to relieve her back pain.
- Ian Hamilton, associate professor of addiction, University of York
- Dr Mark Hallam, clinical director of alcohol and drug service Forward Leeds
- Infographic: What is pregabalin?
- Line chart: Deaths related to pregabalin and gabapentin, 2007-2017
- Column chart: Prescriptions of gabapentin and pregabalin, 2014-2018
- Bar chart: Rise in gabapentin prescriptions, top 10 CCGs
- Bar chart: Rise in pregabalin prescriptions, top 10 CCGs